# Ruby Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ruby-bio

- Industry: Consumer Products
- Headquarters: US
- Website: www.rubybio.com
- Latest round: Seed (Sep 26, 2023)
- Investors on record: 1

## About

Based in California, US, Ruby Bio develops a biosynthesis platform that uses natural yeast to manufacture complex molecules that are biodegradable and non-toxic.? In September 2023, Ruby Bio raised an undisclosed amount of seed funding from investor Alumni Ventures Group.

Ruby Bio uses naturally occurring yeast and its proprietary biosynthesis platform to convert low-cost sugar into complex, biodegradable, and non-toxic molecules. The company partners with industries such as personal and home care, food and beverage, and industrial and agricultural sectors to enable sustainable manufacturing processes. Ruby Bio’s advanced technology produces high-purity, cost-effective ingredients and compounds, tailored to meet performance needs across various applications, including non-toxic ingredients for personal care, optimized formulations for food and beverages, and cost-efficient solutions for industrial and agricultural use.

## Funding rounds

- Seed, Sep 26, 2023 — Alumni Ventures Group

## Investors

- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed